• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Raf/MEK/ERK、PI3K/PTEN/Akt/mTOR和Jak/STAT信号通路在白血病中的作用

Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia.

作者信息

Steelman L S, Abrams S L, Whelan J, Bertrand F E, Ludwig D E, Bäsecke J, Libra M, Stivala F, Milella M, Tafuri A, Lunghi P, Bonati A, Martelli A M, McCubrey J A

机构信息

Department of Microbiology and Immunology, Brody School of Medicine, East Carolina University, Greenville, NC 27858, USA.

出版信息

Leukemia. 2008 Apr;22(4):686-707. doi: 10.1038/leu.2008.26. Epub 2008 Mar 13.

DOI:10.1038/leu.2008.26
PMID:18337767
Abstract

Mutations and chromosomal translocations occur in leukemic cells that result in elevated expression or constitutive activation of various growth factor receptors and downstream kinases. The Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways are often activated by mutations in upstream genes. The Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways are regulated by upstream Ras that is frequently mutated in human cancer. Recently, it has been observed that the FLT-3 and Jak kinases and the phosphatase and tensin homologue deleted on chromosome 10 (PTEN) phosphatase are also frequently mutated or their expression is altered in certain hematopoietic neoplasms. Many of the events elicited by the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways have direct effects on survival pathways. Aberrant regulation of the survival pathways can contribute to uncontrolled cell growth and lead to leukemia. In this review, we describe the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT signaling cascades and summarize recent data regarding the regulation and mutation status of these pathways and their involvement in leukemia.

摘要

白血病细胞中会发生突变和染色体易位,导致各种生长因子受体及下游激酶的表达升高或组成性激活。Raf/MEK/ERK、PI3K/PTEN/Akt/mTOR和Jak/STAT信号通路常因上游基因的突变而被激活。Raf/MEK/ERK和PI3K/PTEN/Akt/mTOR信号通路受上游Ras调控,而Ras在人类癌症中常发生突变。最近发现,FLT-3和Jak激酶以及10号染色体缺失的磷酸酶和张力蛋白同源物(PTEN)磷酸酶在某些造血系统肿瘤中也常发生突变或其表达发生改变。Raf/MEK/ERK、PI3K/PTEN/Akt/mTOR和Jak/STAT信号通路引发的许多事件对生存信号通路有直接影响。生存信号通路的异常调控可导致细胞生长失控并引发白血病。在本综述中,我们描述了Raf/MEK/ERK、PI3K/PTEN/Akt/mTOR和Jak/STAT信号级联反应,并总结了有关这些信号通路的调控、突变状态及其与白血病关系的最新数据。

相似文献

1
Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia.Raf/MEK/ERK、PI3K/PTEN/Akt/mTOR和Jak/STAT信号通路在白血病中的作用
Leukemia. 2008 Apr;22(4):686-707. doi: 10.1038/leu.2008.26. Epub 2008 Mar 13.
2
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.RAF/MEK/ERK和PI3K/PTEN/AKT信号通路在恶性转化和耐药中的作用。
Adv Enzyme Regul. 2006;46:249-79. doi: 10.1016/j.advenzreg.2006.01.004. Epub 2006 Jul 18.
3
Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy.靶向由Ras/Raf/MEK/ERK、PI3K/PTEN/Akt/mTOR和Jak/STAT通路激活所诱导的生存级联反应以实现有效的白血病治疗。
Leukemia. 2008 Apr;22(4):708-22. doi: 10.1038/leu.2008.27. Epub 2008 Mar 13.
4
Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways.由于 Raf/MEK/ERK 和 PI3K/PTEN/Akt/mTOR 信号通路中的突变而导致的治疗抵抗。
J Cell Physiol. 2011 Nov;226(11):2762-81. doi: 10.1002/jcp.22647.
5
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health.Ras/Raf/MEK/ERK和PI3K/PTEN/Akt/mTOR抑制剂:抑制这些通路对人类健康的原理及重要性
Oncotarget. 2011 Mar;2(3):135-64. doi: 10.18632/oncotarget.240.
6
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance.Raf/MEK/ERK信号通路在细胞生长、恶性转化及耐药性中的作用。
Biochim Biophys Acta. 2007 Aug;1773(8):1263-84. doi: 10.1016/j.bbamcr.2006.10.001. Epub 2006 Oct 7.
7
Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy.Ras/Raf/MEK/ERK 通路在白血病治疗中的作用。
Leukemia. 2011 Jul;25(7):1080-94. doi: 10.1038/leu.2011.66. Epub 2011 Apr 15.
8
PI3K/akt, JAK/STAT and MEK/ERK pathway inhibition protects retinal ganglion cells via different mechanisms after optic nerve injury.PI3K/akt、JAK/STAT和MEK/ERK信号通路抑制在视神经损伤后通过不同机制保护视网膜神经节细胞。
Eur J Neurosci. 2007 Aug;26(4):828-42. doi: 10.1111/j.1460-9568.2007.05718.x.
9
Tanshinone IIA can inhibit MiaPaCa‑2 human pancreatic cancer cells by dual blockade of the Ras/Raf/MEK/ERK and PI3K/AKT/mTOR pathways.丹参酮 IIA 可通过双重阻断 Ras/Raf/MEK/ERK 和 PI3K/AKT/mTOR 通路抑制 MiaPaCa-2 人胰腺癌细胞。
Oncol Rep. 2018 Nov;40(5):3102-3111. doi: 10.3892/or.2018.6670. Epub 2018 Aug 23.
10
Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer.针对乳腺癌治疗中的 PI3K/AKT/mTOR 和 Raf/MEK/ERK 通路。
Cancer Treat Rev. 2013 Dec;39(8):935-46. doi: 10.1016/j.ctrv.2013.03.009. Epub 2013 May 3.

引用本文的文献

1
Research progress on the mechanisms of CSF3R mutations in leukemogenesis and treatment strategies.CSF3R突变在白血病发生中的机制及治疗策略的研究进展
Cancer Cell Int. 2025 Aug 14;25(1):304. doi: 10.1186/s12935-025-03941-5.
2
Oxidative stress induces cortical stiffening and cytoskeletal remodelling in pre-apoptotic cancer cells.氧化应激诱导凋亡前癌细胞的皮质硬化和细胞骨架重塑。
Cell Stress. 2025 Aug 7;9:182-193. doi: 10.15698/cst2025.08.310. eCollection 2025.
3
Evaluation of the Circadian Rhythm Component Cipc (Clock-Interacting Pacemaker) in Leukemogenesis: A Literature Review and Bioinformatics Approach.
白血病发生过程中昼夜节律成分Cipc(时钟相互作用起搏器)的评估:文献综述与生物信息学方法
Clocks Sleep. 2025 Jun 25;7(3):33. doi: 10.3390/clockssleep7030033.
4
Novel Camptothecin Derivative 9c with Enhanced Antitumor Activity via NSA2-EGFR-P53 Signaling Pathway.通过NSA2-EGFR-P53信号通路具有增强抗肿瘤活性的新型喜树碱衍生物9c
Int J Mol Sci. 2025 Feb 25;26(5):1987. doi: 10.3390/ijms26051987.
5
Thiazolidinedione derivatives: emerging role in cancer therapy.噻唑烷二酮衍生物:在癌症治疗中的新作用。
Mol Divers. 2025 Feb 3. doi: 10.1007/s11030-024-11093-3.
6
miRNA Profiles in Patients with Hematological Malignancy at Different Stages of the Disease: A Preliminary Study.血液系统恶性肿瘤不同疾病阶段患者的微小RNA谱:一项初步研究
Biomedicines. 2024 Aug 22;12(8):1924. doi: 10.3390/biomedicines12081924.
7
PROteolysis-Targeting Chimeras (PROTACs) in leukemia: overview and future perspectives.白血病中的蛋白酶靶向嵌合体(PROTACs):概述与未来展望。
MedComm (2020). 2024 Jun 5;5(6):e575. doi: 10.1002/mco2.575. eCollection 2024 Jun.
8
The Role of Cytokines in Activation of Tumour-promoting Pathways and Emergence of Cancer Drug Resistance.细胞因子在肿瘤促进途径激活及癌症耐药性产生中的作用
Curr Top Med Chem. 2024;24(6):523-540. doi: 10.2174/0115680266284527240118041129.
9
Lapatinib dysregulates HER2 signaling and impairs the viability of human uveal melanoma cells.拉帕替尼可使HER2信号传导失调,并损害人葡萄膜黑色素瘤细胞的活力。
J Cancer. 2023 Oct 16;14(18):3477-3495. doi: 10.7150/jca.88446. eCollection 2023.
10
MAPK/ERK and PI3K/AKT signaling pathways are activated in adolescent and adult acute lymphoblastic leukemia.丝裂原活化蛋白激酶/细胞外信号调节激酶(MAPK/ERK)和磷酸肌醇 3-激酶/蛋白激酶 B(PI3K/AKT)信号通路在青少年和成人急性淋巴细胞白血病中被激活。
Cancer Rep (Hoboken). 2023 Dec;6(12):e1912. doi: 10.1002/cnr2.1912. Epub 2023 Oct 22.